glucosamine has been researched along with Leishmaniasis, Visceral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, S; Haq, W; Pandey, D; Puri, A; Srivastava, VM | 1 |
Camacho Conde, P; Cintado Bueno, C; Gavilán Camacho, JL; Menéndez Ruiz, M; Navarro González, J; Sosa Alamo, R | 1 |
Farrell, JP; Nolan, TJ | 1 |
3 other study(ies) available for glucosamine and Leishmaniasis, Visceral
Article | Year |
---|---|
Adjunct effect of immunostimulating hexapeptide analogous to human beta-casein fragment (54-59) to sodium stibogluconate against experimental visceral leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; Antimony Sodium Gluconate; Caseins; Cell Migration Inhibition; Cell Proliferation; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Glucosamine; Hemagglutination Tests; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lymphocytes; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Thymus Gland | 2004 |
[Visceral leishmaniasis in childhood (author's transl)].
Topics: Age Factors; Child; Child, Preschool; Female; Glucosamine; Humans; Infant; Injections, Intramuscular; Leishmaniasis, Visceral; Liver; Male; Radionuclide Imaging; Spleen; Technetium | 1980 |
Inhibition of in vivo and in vitro infectivity of Leishmania donovani by tunicamycin.
Topics: Animals; Cells, Cultured; Female; Glucosamine; Glycoproteins; Leishmania; Leishmaniasis, Visceral; Liver; Macrophages; Mice; Mice, Inbred C57BL; Time Factors; Tunicamycin | 1985 |